Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Ribosome-tethered in situ sequencing for single-cell translatome analysis

Created on 29 Jul 2026

Authors

Jiang, M., He, X., Liu, Y., Liu, B., Ma, W., Zhu, L., Lin, C., Zhang, Y., Ke, R.

Abstract

Translational regulation plays a critical role in shaping cellular states and functions, yet approaches for spatially resolved translatome profiling at single-cell resolution remain limited. Here, we develop Ribosome-tethered In Situ Sequencing (Ribo-ISS), an imaging-based spatial translatomics technology that enables high-throughput mapping of ribosome-associated mRNAs in intact tissues. Ribo-ISS integrates ribosome-dependent molecular anchoring with multiplexed in situ sequencing, allowing specific detection of translation-associated transcripts without genetic manipulation or exogenous ribosome labeling. We demonstrate that Ribo-ISS achieves high specificity and enables single-cell spatial translatome profiling in mouse brain, accurately recapitulating major cell types and their anatomical organization. Applied to a sleep deprivation model, Ribo-ISS simultaneously resolved transcriptional and translational changes, revealing extensive transcription-translation uncoupling and distinct cell-type-specific translational responses. Ribo-ISS provides a scalable framework for investigating spatially organized translational programs and expands the capability of spatial omics toward understanding gene regulation beyond transcription.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 29 Jul 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 13
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement